John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Expeditors International
EXPD
$24.8B
| $705K | ﹤0.01% |
5,802
+2
| +0% | +$247 |
|
2127
BlackBerry
BB
$4.59B
| $702K | ﹤0.01% |
+254,240
| New | +$743K |
|
|
MCBC
2128
DELISTED
Macatawa Bank Corp
MCBC
| $702K | ﹤0.01% |
71,658
+26,281
| +58% | +$269K |
|
2129
Towne Bank
TOWN
$3.49B
| $700K | ﹤0.01% |
24,958
+14,658
| +142% | +$407K |
|
2130
NCR Atleos
NATL
$3.43B
| $700K | ﹤0.01% |
35,448
+20,948
| +144% | +$448K |
|
2131
Fidelity MSCI Communication Services Index ETF
FCOM
$1.79B
| $699K | ﹤0.01% |
14,100
-10,300
| -42% | -$488K |
|
2132
BioAtla
BCAB
$5.46M
| $699K | ﹤0.01% |
4,062
+645
| +19% | +$80.1K |
|
|
ZEUS
2133
DELISTED
Olympic Steel
ZEUS
| $697K | ﹤0.01% |
9,840
-13,550
| -58% | -$905K |
|
2134
SP Funds S&P 500 Sharia ETF
SPUS
$3.07B
| $697K | ﹤0.01% |
18,400
-8,100
| -31% | -$292K |
|
2135
Hagerty
HGTY
$1.35B
| $696K | ﹤0.01% |
76,119
+44,809
| +143% | +$375K |
|
2136
Kodak
KODK
$925M
| $692K | ﹤0.01% |
139,769
-63,809
| -31% | -$256K |
|
2137
Bentley Systems
BSY
$11.2B
| $690K | ﹤0.01% |
13,204
-11,896
| -47% | -$599K |
|
|
CSR
2138
Centerspace
CSR
$907M
| $689K | ﹤0.01% |
+12,059
| New | +$671K |
|
2139
Celanese
CE
$4.88B
| $688K | ﹤0.01% |
4,002
-10,498
| -72% | -$1.6M |
|
2140
Tyra Biosciences
TYRA
$1.59B
| $685K | ﹤0.01% |
+41,742
| New | +$685K |
|
2141
Pampa Energía
PAM
$4.29B
| $684K | ﹤0.01% |
15,846
-2,000
| -11% | -$89.1K |
|
2142
AMN Healthcare
AMN
$1.32B
| $682K | ﹤0.01% |
10,913
-4,380
| -29% | -$298K |
|
2143
Bridgewater Bancshares
BWB
$586M
| $680K | ﹤0.01% |
58,418
+6,329
| +12% | +$77.1K |
|
2144
PMV Pharmaceuticals
PMVP
$70M
| $680K | ﹤0.01% |
399,710
+121,009
| +43% | +$226K |
|
2145
Santander
BSBR
$43.7B
| $679K | ﹤0.01% |
+118,675
| New | +$697K |
|
|
JBIO
2146
Jade Biosciences
JBIO
$1.36B
| $678K | ﹤0.01% |
655
+376
| +135% | +$287K |
|
2147
Dave Inc
DAVE
$4.6B
| $677K | ﹤0.01% |
+18,222
| New | +$420K |
|
2148
Liquidity Services
LQDT
$1.36B
| $676K | ﹤0.01% |
36,342
-67,774
| -65% | -$1.18M |
|
2149
PLAYSTUDIOS Inc
MYPS
$61.4M
| $675K | ﹤0.01% |
242,771
+18,511
| +8% | +$43K |
|
2150
ASE Group
ASX
$96.8B
| $675K | ﹤0.01% |
61,400
| – | – |
|
Similar funds
John Overdeck's Q1 2024 Portfolio in Review
As of Q1 2024, John Overdeck held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
John Overdeck withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, John Overdeck opened a new position in Pfizer worth $234M.
- John Overdeck's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- John Overdeck added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- John Overdeck's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- John Overdeck fully exited Rivian in Q1 2024, selling an estimated $158M.
- John Overdeck's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- John Overdeck opened 408 new positions and closed 532 in Q1 2024.
- John Overdeck's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.